Bronchogen 20mg

▎Bronchogen Structure

▎Bronchogen Research

What is the research background of Bronchogen?

In the current field of medical research, respiratory diseases have always been a focus of global attention. According to authoritative data, in recent years, the incidence rates of various respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and chronic bronchitis have been increasing year by year, seriously threatening human health and quality of life. When dealing with these complex diseases, traditional treatment methods often have problems such as curative effect bottlenecks and side effects, making the development of new, efficient, and safe treatment regimens an urgent task in the medical field.

Against this backdrop, researchers have focused on exploring substances with special biological activities from various biological resources that can repair and protect the bronchial tissues. They have used advanced molecular biology techniques and high-throughput screening methods to conduct systematic research on a large number of bioactive components. After long-term unremitting efforts, Bronchogen was discovered. It may originate from the metabolic products of specific cells in certain organisms or be secreted by specific tissues under special physiological conditions, and it has the unique ability to regulate the physiological functions related to the bronchi, opening up a new research direction for the treatment of respiratory diseases and promising to be the key to breaking through the existing treatment difficulties.

What is the mechanism of action of Bronchogen?

1. Effects in Lung Disease Models

Inhibiting Inflammation: In the chronic obstructive pulmonary disease (COPD) model, Bronchogen has an impact on the structural and functional status of the bronchial epithelium and the inflammatory activity of the lungs. By creating a COPD model in rats through 60 days of intermittent nitrogen dioxide exposure, it was found that after treatment with the Bronchogen peptide, the inflammatory activity of neutrophils decreased, and the cell composition in bronchoalveolar lavage fluid (BALF) and the distribution of pro-inflammatory cytokines and enzymes returned to normal. This indicates that Bronchogen can inhibit the inflammatory response in the lungs ^{[1, 2]}.

Restoring the Structure and Function of the Bronchial Epithelium: During the formation of the COPD model, the structure of the bronchial epithelium was damaged, but the treatment with Bronchogen restored this structure, and its functional activity was also restored. This can be demonstrated by the increase in secretory immunoglobulin A (a local immune marker) and surfactant protein B, which is responsible for reducing the surface tension of the alveoli^{[1, 2]}.

2. Effects on the Thermal Stability of DNA

Stabilizing the DNA Structure: Studies have shown that Bronchogen can act as a DNA stabilizer. Within a certain concentration range (the molar ratio of bronchogen/DNA base pairs is 0.01 - 0.055), Bronchogen can increase the melting temperature of DNA from calf thymus and mouse liver by 3.1°C^[3]. However, further increasing this ratio does not change the melting temperature. Within this range, the melting enthalpy (ΔH (melt)) of the complex remains unchanged, and the ΔH (melt) of DNA from calf thymus and mouse liver is 11.4 and 12.7 cal/g respectively. This shows that Bronchogen is not an adenine-thymine-specific or guanine-cytosine-specific ligand, and the type of its binding is a strong and accidental binding, mainly binding to the two strands of DNA (mainly the nitrogenous bases)^[3].

What are the applications of Bronchogen?

1. Chronic Bronchitis

Bronchogen plays an important role in the treatment of chronic bronchitis. Chronic bronchitis is a common respiratory disease, and patients often present with symptoms such as coughing, expectoration, and dyspnea^[2]. Bronchogen can relieve the symptoms of patients by reducing the inflammatory response and alleviating the congestion and edema of the bronchial mucosa. At the same time, it can also promote the repair and regeneration of bronchial tissues, enhancing the elasticity and function of the bronchi. During long-term treatment, the coughing frequency and expectoration volume of patients gradually decrease, and the degree of dyspnea is significantly improved.

2. Asthma

In the management of asthma, Bronchogen has shown great potential. Asthma is a chronic inflammatory disease of the airway, and the airways of patients are highly sensitive to various stimuli, prone to symptoms such as bronchospasm and dyspnea. Bronchogen can improve airway function by reducing bronchial inflammation and decreasing the hyperresponsiveness of the airway. It can regulate the immune system, reduce the infiltration of inflammatory cells and the release of inflammatory mediators, thereby alleviating the symptoms of asthma patients. In addition, Bronchogen can also enhance lung health and improve the lung function of patients, enabling them to better cope with various challenges in daily life.

3. Chronic Obstructive Pulmonary Disease (COPD)

For patients with chronic obstructive pulmonary disease, Bronchogen is an effective treatment. COPD is a progressive respiratory disease, and patients often present with symptoms such as coughing, expectoration, and shortness of breath. The effects of Bronchogen in COPD patients mainly include promoting tissue repair, improving bronchial function, and reducing inflammation. It can stimulate the regeneration of bronchial epithelial cells, repair the damaged bronchial tissues, and improve the patency of the bronchi. At the same time, Bronchogen can also reduce the inflammatory response, alleviate the inflammatory damage in the lungs, and delay the progression of the disease. Through these effects, Bronchogen can improve the quality of life of patients, reduce the number of acute exacerbations, and extend the survival period of patients.

4. Recovery after Acute Respiratory Infections

After acute respiratory infections (such as pneumonia), Bronchogen can be used to support the recovery of patients. Acute respiratory infections can cause serious damage to the bronchial and lung tissues, affecting the respiratory function of patients. Bronchogen can accelerate the repair of bronchial tissues, promote the regeneration of damaged cells, and restore the normal structure and function of the bronchi^[4]. It can also improve respiratory function, enhance the gas exchange ability of the lungs, and reduce the risk of long-term damage. After using Bronchogen, patients breathe more smoothly, regain their strength gradually, and can return to normal life and work more quickly.

5. Protection of Lung Function in Smokers

For smokers or people exposed to environmental pollution, Bronchogen helps protect and repair the bronchi. Smoking and environmental pollution can cause serious damage to the respiratory system and increase the risk of chronic lung diseases. Bronchogen can reduce the damage of harmful substances to the bronchial and lung tissues and promote the repair and regeneration of the bronchi^[5]. It can enhance the defensive function of the bronchi, reduce the inflammatory response, and decrease the occurrence of lung diseases. In addition, Bronchogen can also improve lung function, enhance the respiratory quality of smokers, and slow down the development rate of chronic lung diseases.

6. Auxiliary Role in Comprehensive Treatment

Bronchogen can be used as an adjuvant to traditional treatment to enhance the therapeutic effect. In the treatment of diseases such as cough syndrome, combining Bronchogen with traditional treatment methods can improve the overall curative effect.

Bronchogen is useful for the following groups of people:

In conclusion, Bronchogen shows important value in the field of life sciences. It can stabilize the DNA structure, providing a new direction for the study of DNA-related mechanisms. In the treatment of respiratory diseases, for conditions such as chronic bronchitis, asthma, and COPD, it can effectively reduce inflammation, promote tissue repair, significantly improve the respiratory status of patients, relieve symptoms, and improve the quality of life, which is of profound significance for the prevention and treatment of respiratory diseases.

About The Author

The above-mentioned materials are all researched, edited and compiled by Cocer Peptides.

Scientific Journal Author

Caswell S J is a distinguished researcher affiliated with several prominent institutions, including AstraZeneca, the Francis Crick Institute, TDHB, the University of British Columbia, and ALVANLEY CLIN. His research spans a wide array of fields, reflecting his interdisciplinary expertise. In Biochemistry & Molecular Biology, he has contributed to advancing the understanding of cellular processes and molecular interactions. His work in General & Internal Medicine has implications for improving patient care and treatment protocols.

In the realm of Virology, Caswell S J has explored viral mechanisms and host interactions, which is crucial for developing antiviral strategies. His involvement in Science & Technology - Other Topics indicates his engagement with innovative methodologies and technologies that transcend traditional scientific boundaries. Furthermore, his research in Parasitology has shed light on parasitic diseases and their impact on public health. Through his multifaceted research, Caswell S J has made significant contributions to the scientific community, influencing both theoretical advancements and practical applications in medicine and biology. Caswell S J is listed in the reference of citation [4].

▎Relevant Citations

[1]    Kuzubova N A, Lebedeva E S, Dvorakovskaya I V, et al. Modulating Effect of Peptide Therapy on the Morphofunctional State of Bronchial  Epithelium in Rats with Obstructive Lung Pathology[J]. Bulletin of Experimental Biology and Medicine, 2015,159(5):685-688.DOI:10.1007/s10517-015-3047-x.

[2]    Titova O N, Kuzubova N A, Lebedeva E S, et al. Antiinflammatory and regenerative effect of peptide therapy in the model of obstructive lung pathology [J]. Ross Fiziol Zh Im I M Sechenova, 2017,103(2):201-208. https://pubmed.ncbi.nlm.nih.gov/30199201/.

[3]    Monaselidze J R, Khavinson V K, Gorgoshidze M Z, et al. Effect of the peptide bronchogen (Ala-Asp-Glu-Leu) on DNA thermostability[J]. Bulletin of Experimental Biology and Medicine, 2011,150(3):375-377.DOI:10.1007/s10517-011-1146-x.

[4]    Caswell S J, Thomson A H, Ashmore S P, et al. latent sensitization to respiratory syncytial virus during acute bronchiolitis and lung-function after recovery[J]. archives of disease in childhood, Archives of Disease in Childhood, 1990,65(9):946-952.DOI:10.1136/adc.65.9.946.

[5]    Yoshida M, Kaneko Y, Ishimatsu A, et al. Effects of tiotropium on lung function in current smokers and never smokers with bronchial asthma[J]. Pulmonary Pharmacology & Therapeutics, 2017,42:7-12.DOI:10.1016/j.pupt.2016.11.004.

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE SOLELY FOR INFORMATION DISSEMINATION AND EDUCATIONAL PURPOSES.  

The products provided on this website are intended exclusively for in vitro research. In vitro research (Latin: *in glass*, meaning in glassware) is conducted outside the human body. These products are not pharmaceuticals, have not been approved by the U.S. Food and Drug Administration (FDA), and must not be used to prevent, treat, or cure any medical condition, disease, or ailment. It is strictly prohibited by law to introduce these products into the human or animal body in any form.